Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Pharma titan Eli Lilly on Thursday reported strong demand for its weight loss and diabetes drugs Zepbound and Mounjaro , smashing analysts’ expectations in the face of Eli Lilly reported $11.3 billion in revenue and $2.97 billion in net profit for the second quarter of 2024.
Lilly reported $3.28 earnings per share, besting expectations of $2.74, and raised the range of its annual forecast $2.05 to earnings per share between $15.10 to $15.60.
Novo Nordisk Tirzepatide Zepbound Mounjaro Ozempic Wegovy Weight Loss Earnings Profit
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Intel, Nvidia, Eli Lilly rise premarket; BP, Novo Nordisk fallIntel, Nvidia, Eli Lilly rise premarket; BP, Novo Nordisk fall
Read more »
Novo Nordisk stock price falls after Eli Lilly weight loss drug outperforms OzempicPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
Wednesday's analyst calls: Eli Lilly gets a price target increase, Goldman sees Tesla declineTesla and a pharmaceutical giant were among the stocks analysts were talking about on Wednesday.
Read more »
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche's latest obesity drug candidate.
Read more »
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche’s latest obesity drug candidate.
Read more »
Nvidia, TSMC, Five Below, Spirit Airlines and Eli Lilly fall premarketNvidia, TSMC, Five Below, Spirit Airlines and Eli Lilly fall premarket
Read more »